Clinical trial Recruiting at 1 site Observational Ages 65 and up

Managing multiple medications in older adults with chronic diseases

Official title: Assessment and Management of Multiple Drug Use in Elderly Chronic Disease Patients

Run by Xijing Hospital · NCT07180368 · Data updated 2026-11-12

This project will see if taking many different medicines changes the health outlook of people aged 65 and older who have chronic conditions.

Quick facts

Study typeObservational
Ages65 Years and up
SexAll
Enrollment2000 (estimated)
SponsorXijing Hospital
Academic / other
Locations1 site (Xi'an, Shaanxi)
StatusRecruiting
StartedOctober 1, 2024
Main results expectedSeptember 30, 2026
Study endsSeptember 30, 2027
Registry record updatedSeptember 18, 2025
Trial IDNCT07180368 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal participants are people aged 65 or older with at least one chronic disease, stable vital signs, and willingness to complete online surveys over two years.

Probably not a fit

People without chronic diseases, those with unstable vital signs, or individuals unwilling or unable to participate in online surveys are unlikely to gain benefit from this project.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study follows patients aged 65 and older with one or more chronic diseases to see how polypharmacy relates to their prognosis over two years. Participants at Xijing Hospital will complete periodic online surveys about their medications, symptoms, and health events. No experimental treatments are given; researchers will analyze survey data to link medication burden with outcomes such as hospitalization, disease progression, or mortality. The goal is to identify medication patterns associated with poorer prognosis and inform safer prescribing for older adults.

Why it matters

Potential benefit: If successful, the findings could help clinicians simplify medication regimens and reduce harm, improving quality of life and health outcomes for older patients.

How similar studies have gone: Previous observational research has repeatedly linked polypharmacy to worse outcomes in older adults, while interventional deprescribing studies have shown mixed but sometimes positive results.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients aged 65 years or older with at least one chronic disease

Exclusion Criteria:

* Patients without chronic diseases
* Patients refused to participate in the study
* Patients with unstable vital signs

Where it's running

  • Xijing Hospital
    Xi'an, Shaanxi, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.